发明名称 PROTON NMR SPECTROSCOPY FOR BIOCHEMICAL SCREENING
摘要 High-Throughput Screening (HTS) of large compound libraries is the method of choice for discovery of lead compounds for drug development. The present invention provides novel, sensitive and broadly applicable NMR screening methods in which the H8 signal of a purine-containing substrate or product, or the H6 signal of a pyrimidine-containing substrate or product, is used to monitor enzymic reactions that utilize such substrates. Experiments can be performed in real time or in an endpoint assay format using protein and substrate concentrations comparable to the ones used by other HTS techniques. Application of the NMR method to the assay of the enzymes creatine kinase and phosphodiesterase 2A is presented. The methods are applicable to any of a multitude of enzymes that utilize purine nucleoside substrates (e.g. ATP, GTP) or pyrimidine nucleoside substrates (e.g. CTP, UDP-GlcNac), including protein kinases, GTPases, and lipid kinases.
申请公布号 WO2013078138(A1) 申请公布日期 2013.05.30
申请号 WO2012US65893 申请日期 2012.11.19
申请人 OSI PHARMACEUTICALS, LLC 发明人 LI, YINGJIE;MA, LIFU;MULVIHILL, MARK, J.
分类号 C12Q1/00;C12Q1/30;C12Q1/48 主分类号 C12Q1/00
代理机构 代理人
主权项
地址